Safety, tolerability, and pharmacokinetics of PL 14736, a novel agent for treatment of ulcerative colitis, in healthy male volunteers
et al., 2023) and colorectal cancer (Xiao et al., 2021
Reported outcomes included changes in mitochondrial complex activity (complexes I, II, and IV), increased complex I activity, enhancement of antioxidant defenses, and reduced protein oxidation in brain tissue [90]
Choosing sites with a reasonable depth of subcutaneous tissue, and ensuring adequate injection depth into the subcutaneous layer rather than intradermally or intramuscularly, reduces direct nerve stimulation and the associated discomfort
Upon entering the intestinal tract, probiotics interact dynamically with the resident bacterial community
Shared risk factors in cardiovascular disease and cancer